Cargando…
Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development
Non-alcoholic fatty liver disease (NAFLD), the most frequent cause of chronic liver disease worldwide, is associated with a plethora of metabolic comorbidities such as obesity, prediabetes, type 2 diabetes mellitus, hypertension and dyslipidemia but may be present in a significant percentage of non-...
Autores principales: | Liu, Junli, Dalamaga, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646175/ https://www.ncbi.nlm.nih.gov/pubmed/34917917 http://dx.doi.org/10.1016/j.metop.2021.100153 |
Ejemplares similares
-
DRAK2-SRSF6-regulated RNA alternative splicing is a promising therapeutic target in NAFLD/NASH
por: Dalamaga, Maria, et al.
Publicado: (2021) -
Favorable effects of Anethum graveolens on liver oxidative stress and cholesterol 7 alpha-hydroxylase levels in non-alcoholic fatty liver disease (NAFLD) rat models
por: Abbasi, Ebrahim, et al.
Publicado: (2021) -
Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021) -
Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
por: Bernstein, David, et al.
Publicado: (2022) -
Protective effects of cerium oxide nanoparticles in non-alcoholic fatty liver disease (NAFLD) and carbon tetrachloride-induced liver damage in rats: Study on intestine and liver
por: Abbasi, Ebrahim, et al.
Publicado: (2021)